EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 21 May 2026

Patients in Europe waiting longer for new medicines as inequality grows between Member States

Read more here.

The latest WAIT Indicator shows a system under strain. This is not new, but it is getting worse.

The median time to availability is 532 days, ranging from 56 days in Germany to 1,201 days in Romania
49% of medicines are not available to patients in Europe

And the pressure is no longer just internal. The introduction of the MFN could further influence where and when new medicines are launched, with implications for access in Europe.

EFPIA and Vaccines Europe welcome the Commission’s Global Health Resilience Initiative and...
20 May 2026

EFPIA and Vaccines Europe welcome the publication of the European Commission Communication on “Reinforcing Global Health... Read more

Events

European Conference on Rare Diseases and Orphan Products (ECRD) 2026
03 June 2026 (Prague & Online)

The next ECRD will be held on 3 & 4 June 2026 in Prague and will be titled “Rare Diseases in a Changing & Competitive... Read more

Scaling Competitive Biopharma in Europe
03 June 2026 (London & Online)

This high-level briefing from the Financial Times, in partnership with Syneos Health, will bring together leading executives... Read more

What we are reading

Monitoring the European clinical trials environment
On 20 May 2026 (European Commission)

The metrics in this report provide information on the trend of the clinical research environment in the European... Read more

Joint Declaration on Strengthening the Pharmaceutical Industry in Europe
On 18 May 2026 (German and French Ministries of Health)

With approximately 520 million inhabitants in the EU and EEA and boasting almost universal health coverage, Europe... Read more

Vaccines and ageing: Helping older people decide
On 15 May 2026 (Vaccines Today)

Older adults can be protected against serious illness. How can healthcare professionals support them in making informed... Read more

Countries compete to reform trials in a bid to attract global sponsors
On 14 May 2026 (Yahoo! Finance)

Clinical trial reforms have become abundant across the global pharmaceutical industry as regions look to stake their... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu